Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Czechia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20091
20111
20123
20131
20141
20151
20171
20181
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2
Terminated2
No longer available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
European LeukemiaNet1
III. Medizinische Klinik Mannheim1
Pfizer1
Poitiers University Hospital1
St. Anna Kinderkrebsforschung1
Takeda1
University of Jena1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive18
Leukemia8
Leukemia, Myeloid6
Bone Marrow Diseases5
Hematologic Diseases4
Myeloproliferative Disorders4
Neoplasms by Histologic Type3
Philadelphia Chromosome3
Hematologic Neoplasms2
Leukemia, Myeloid, Chronic-Phase2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.